Rolling Hills Healthcare: Insulin Doses Missing - IN
Rolling Hills Healthcare Center failed to record administration of Lantus insulin for Resident B on eight separate mornings between August 2 and September 7, federal inspectors found during a September 8 complaint investigation.
The resident has diabetes, hypertension, non-Alzheimer's dementia, anxiety, and depression. A July assessment indicated moderate cognitive impairment. The person required 30 units of Lantus insulin twice daily — morning and bedtime — according to a physician's order dating back to March 24.
But the facility's Electronic Medication Administration Record showed blank entries for morning insulin doses on August 2, August 3, August 9, August 10, August 23, August 30, August 31, and September 7. No progress notes explained the missed doses.
The clinical record contained no documentation that the resident was out of the building when medications weren't administered.
When inspectors interviewed RN 2 at 2:56 p.m. on September 8, the nurse said all medications should be initialed in the electronic record. If medication wasn't given, staff should have written a progress note explaining why.
The Clinical Support Nurse, interviewed nine minutes later, offered a different explanation. That nurse said blank entries in the medication record could mean staff forgot to sign out the medication or the physician's order had changed.
Neither explanation matched what inspectors found. The physician's order for twice-daily insulin remained current and unchanged since March. No progress notes documented refusal, illness, or other reasons for withholding the medication.
Rolling Hills' own medication administration policy, provided to inspectors at 3:41 p.m., required documentation when medications are "refused or withheld or not given." The policy stated that medication documentation must be current and follow accepted nursing standards.
The facility violated federal requirements for pharmaceutical services by failing to document medication administration for the diabetic resident with dementia.
Lantus is a long-acting insulin used to control blood sugar in diabetic patients. Missing doses can cause dangerous spikes in blood glucose levels, particularly risky for residents with cognitive impairment who may not recognize or communicate symptoms of high blood sugar.
The inspection occurred in response to a complaint filed against the facility. Federal regulators classified the violation as causing minimal harm or potential for actual harm, affecting few residents.
Rolling Hills must submit a plan of correction to continue participating in Medicare and Medicaid programs. The facility has 14 days from receiving the inspection report to make findings and correction plans publicly available.
The missing insulin documentation represents a breakdown in basic medication safety protocols that nursing homes must follow to protect vulnerable residents who depend entirely on staff for life-sustaining treatments.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Rolling Hills Healthcare Center from 2025-09-08 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
ROLLING HILLS HEALTHCARE CENTER in NEW ALBANY, IN was cited for violations during a health inspection on September 8, 2025.
The resident has diabetes, hypertension, non-Alzheimer's dementia, anxiety, and depression.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.